Confidential Treatment. The parties hereto understand that any information or recommendation supplied by the Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Investment Manager, the Company or such persons the Investment Manager may designate in connection with the Fund. The parties also understand that any information supplied to the Sub-Adviser in connection with the performance of its obligations hereunder, particularly, but not limited to, any list of securities which may not be bought or sold for the Fund, is to be regarded as confidential and for use only by the Sub-Adviser in connection with its obligation to provide investment advice and other services to the Fund.
Confidential Treatment. Customer understands that certain commercial and financial information contained in this Letter Agreement are considered by Boeing as confidential. Customer agrees that it will treat this Letter Agreement and the information contained herein as confidential and will not, without the prior written consent of Boeing, disclose this Letter Agreement or any information contained herein to any other person or entity.
Confidential Treatment. All information and advice furnished by one party to the other party (including their respective agents, employees and representatives and the agents, employees, and representatives of any affiliates) hereunder shall be treated as confidential and shall not be disclosed to third parties, except as may be necessary to comply with applicable laws, rules and regulations, subpoenas, court orders, and as required in the administration and management of the Funds. It is understood that any information or recommendation supplied or produced by Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Adviser and the Trust. Without limiting the foregoing, the Adviser and the Trust will only disclose portfolio information in accordance with the Trust’s portfolio information policy as adopted by the Board of Trustees.
Confidential Treatment. Customer understands that Boeing considers certain commercial and financial information contained in this business consideration as confidential. Each of Customer and Boeing agree that it will treat this business consideration and the information contained herein as confidential. Customer agrees to limit the disclosure of the contents of this business consideration to employees of Customer with a need to know and who understand that they are not to disclose its content to any other person or entity without the prior written consent of Boeing. Notwithstanding the foregoing, Customer may disclose this business consideration and the terms and conditions herein to its parent company, FedEx Corporation, to the Board of Directors of its parent corporation, FedEx Corporation, to its professional advisors under a duty of confidentiality with respect hereto, and as required by law. BOEING PROPRIETARY SA-30 *Blank spaces contained confidential information which has been filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended. Very truly yours, THE BOEING COMPANY FEDERAL EXPRESS CORPORATION By /s/ L. Xxxxxxx Xxxxxx By /s/ Xxxxxxx X. Xxxx Its Attorney-In-Fact Its Vice President Aircraft Acquisitions & Planning and Performance ACCEPTED AND AGREED TO this Date: June 18, 2018 SA-30 The Boeing Company X.X. Xxx 0000 Xxxxxxx, XX 00000-0000 FED-PA-3157-LA-1802894 FedEx contract # Federal Express Corporation 0000 Xxxxxxxx Xxxx Xxxxxxx, XX 00000 Subject: Special Matters for Block E Aircraft References: Purchase Agreement No. 3157 (the Purchase Agreement) between The Boeing Company (Boeing) and Federal Express Corporation (Customer) relating to Model 777-FREIGHTER aircraft (the Aircraft) This letter agreement (Letter Agreement) amends and supplements the Purchase Agreement. All terms used but not defined in this Letter Agreement have the same meaning as in the Purchase Agreement. The terms of this Letter Agreement apply to Block E1 Aircraft in Table 1-E1 and Block E2 Aircraft in Table 1-E2 (collectively, Block E Aircraft).
Confidential Treatment. The information contained herein represents confidential business information and has value precisely because it is not available generally or to other parties. AAL-PA-03735-LA-1106664R1 BOEING PROPRIETARY [*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] Customer will limit the disclosure of its contents to employees of Customer with a need to know the contents for purposes of helping Customer perform its obligations under the Purchase Agreement and who understand they are not to disclose its contents to any other person or entity without the prior written consent of Boeing. Very truly yours, THE BOEING COMPANY By: /s/ The Boeing Company Its: Attorney-In-Fact ACCEPTED AND AGREED TO this Date: March 6, 2015 AMERICAN AIRLINES, INC. By: /s/ American Airlines, Inc. Its: Vice President Fleet Planning AAL-PA-03735-LA-1106664R1 BOEING PROPRIETARY [*CTR]=[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] Attachment to Letter Agreement No. AAL-PA-03735-LA-1106664R1 [*CTR] [*CTR] FOR AMERICAN AIRLINES, INC. SECTION CONTENTS 1 AIRCRAFT MODEL APPLICABILITY 2 FLIGHT PERFORMANCE 3 AIRCRAFT CONFIGURATION 4 GUARANTEE CONDITIONS 5 GUARANTEE COMPLIANCE
Confidential Treatment. All information and advice furnished by one party to the other party (including their respective agents, employees and representatives) hereunder shall be treated as confidential and shall not be disclosed to third parties, except as may be necessary to comply with applicable laws, rules and regulations, subpoenas or court orders. It is understood that any information or recommendation supplied by, or produced by, Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Adviser and the Trust. Without limiting the foregoing, the Adviser and the Trust will only disclose portfolio information in accordance with the Trust’s portfolio information policy as adopted by the Board of Trustees.
Confidential Treatment. Customer understands that Boeing considers certain commercial and financial information contained in this Letter Agreement as confidential. Each of Customer and Boeing agree that it will treat this Letter Agreement and the information contained herein as confidential. Customer agrees to limit the disclosure of the contents of this Letter Agreement to employees of Customer with a need to know and who understand that they are not to disclose its content to any other person or entity without the prior written consent of Boeing. Notwithstanding the forgoing, Customer may disclose this Letter Agreement and the terms and conditions herein to its parent company, FedEx Corporation, to the Board of Directors of its parent corporation, FedEx Corporation, to its professional advisors under a duty of confidentiality with respect hereto, and as required by law. Very truly yours, THE BOEING COMPANY By /s/ XXXXXX X. XXXX Its Attorney-In-Fact ACCEPTED AND AGREED TO this Date: December 14, 2011 Federal Express Corporation By /s/ XXXXXXX X. XXXX Its Vice President Attachments A and B BOEING PROPRIETARY Attachment A to Letter Agreement FED-PA-03712-LA-1106152 [ * ] * Blank spaces contained confidential information which has been filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended. XXX-XX-00000-XX-0000000 Xxxxxxxxxx A December 12, 2011 Page 1 BOEING PROPRIETARY Attachment B to Letter Agreement FED-PA-03712-LA-1106152 [ * ] * Blank spaces contained confidential information which has been filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended. XXX-XX-00000-XX-0000000 Xxxxxxxxxx B December 12, 2011 Page 1 BOEING PROPRIETARY The Boeing Company X.X. Xxx 0000 Xxxxxxx, XX 00000-0000 FED-PA-03712-LA-1106153 Federal Express Corporation 0000 Xxxxx Xxxxx Xxxx Xxxxxxx XX 00000 Subject: Liquidated Damages – Non-Excusable Delay Reference: Purchase Agreement No. 3712 (Purchase Agreement) between The Boeing Company (Boeing) and Federal Express Corporation (Customer) relating to Model 767-3S2F aircraft (Aircraft) This letter agreement (Letter Agreement) amends and supplements the Purchase Agreement. All terms used but not defined in this Letter Agreement shall have the same meaning as in the Purchase Agreement.
Confidential Treatment. Customer and Boeing understand that certain commercial and financial information contained in this Letter Agreement are considered by Boeing and Customer as confidential. Customer and Boeing agree that each will treat this Letter Agreement and the information contained herein as confidential and will not, without the prior written consent of the other, disclose this Letter Agreement or any information contained herein to any other person or entity, except as provided in this Letter Agreement or in the Applicable Purchase Agreements. Very truly yours, THE BOEING COMPANY By Its Attorney-In-Fact ACCEPTED AND AGREED TO this ____ day of , 2008 AMERICAN AIRLINES, INC. By Its Attachment A: Information regarding MADP Rights Attachment B: Information regarding QADP Rights Attachment C: Description and Price for Eligible Models Attachment D: Form of Purchase Agreement Supplement Attachment E: Letter Agreements PA Nx. 0000 Xxxxxxxx Xxxxxxxx Rights and Substitution Rights BOEING PROPRIETARY Attachment A to Letter Agreement 6-1162-TRW-0664 MADP Option Rights Aircraft Exercise Lead Time Exercise Date [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] PA 3219 Page 1 of 1 Attachment B to Letter Agreement 6-1162-TRW-0664 QADP Option Rights Aircraft Exercise Lead Time Exercise Date [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] PA 3219 Page 1 of 1 Attachment C to Letter Agreement 6-1162-TRW-0664 Rights Aircraft Delivery, Description, Price and Advance Payments [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] AAL 48980-1O.TXT Page 1 Attachment C to Letter Agreement 6-1162-TRW-0664 Rights Aircraft Delivery, Description, Price and Advance Payments [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] AAL 48980-1O.TXT Page 2 Attachment C to Letter Agreement 6-1162-TRW-0664 Rights Aircraft Delivery, Description, Price and Advance Payments [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] AAL 48980-1O.TXT Page 3 Attachment C to Letter Agreement 6-0000-0000 Rights Aircraft Delivery, Description, Price and Advance Payments [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TRE...
Confidential Treatment. The information contained herein represents confidential business information and has value precisely because it is not available generally or to other parties. This Letter Agreement shall be subject to the terms and conditions of Letter Agreement No. AAL-PA-03735-LA-1106670R1 entitled “Confidentiality”. (Intentionally Left Blank) AAL-PA-03735-LA-1106652R3 SA-32 [****] Page 3 of 5 BOEING AND AMERICAN PROPRIETARY Very truly yours, THE BOEING COMPANY By: /s/ The Boeing Company Its: Attorney-In-Fact ACCEPTED AND AGREED TO this Date: AMERICAN AIRLINES, INC. By: /s/ American Airlines, Inc. Its: Sr Vice President, Treasurer AAL-PA-03735-LA-1106652R3 SA-32 BOEING AND AMERICAN PROPRIETARY Attachment A(R3) To Letter Agreement No. AAL-PA-03735-LA-1106652R3 [****] Aircraft Delivery, Description, Price and Advance Payments Airframe Model/MTOW: [****] [****] Configuration Specification: [****] Engine Model/Thrust: CFMLEAP-1B21 [****] Airframe Price Base Year/Escalation Formula: [****] [****] Airframe Price: $[****] Engine Price Base Year/Escalation Formula: Optional Features: $[****] Sub-Total of Airframe and Features: $[****] Airframe Escalation Data: Engine Price (Per Aircraft): $[****] Base Year Index (ECI): [****] Aircraft Basic Price (Excluding BFE/SPE): $[****] Base Year Index (CPI): [****] Buyer Furnished Equipment (BFE) Estimate: $[****] Seller Purchased Equipment (SPE)/In-Flight Entertainment (IFE) Estimate: $[****] LIFT Seats Provided by Boeing (Estimate): $[****] Deposit per Aircraft: $[****] Escalation Escalation Estimate Advance Payment Per Aircraft (Amts. Due/Mos. Prior to Delivery): Delivery Number of Factor Orig Scheduled Nominal Adv Payment Base At Signing [****] [****] Total Date Aircraft (Airframe) Deliv Date Delivery Price Per A/P [****] [****] [****] [****] [****]-2024 1 [****] [****] [****] [****] [****] [****] [****] [****]-2024 2 [****] [****] [****] [****] [****] [****] [****] [****]-2024 2 [****] [****] [****] [****] [****] [****] [****] [****]-2024 2 [****] [****] [****] [****] [****] [****] [****] [****]-2024 2 [****] [****] [****] [****] [****] [****] [****] [****]-2024 2 [****] [****] [****] [****] [****] [****] [****] [****]-2025 1 [****] [****] [****] [****] [****] [****] [****] [****]-2025 1 [****] [****] [****] [****] [****] [****] [****] [****]-2025 1 [****] [****] [****] [****] [****] [****] [****] [****]-2026 1 [****] [****] [****] [****] [****] [****] [****] [****]-2026 2 [****] [****] [****] [****] [****] [****] [****] [****]-2026...
Confidential Treatment. It is understood that any information or recommendation supplied by, or produced by, Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Adviser and the Trust. Furthermore, except as required by law (including, but not limited to semi-annual, annual or other filings made under the 0000 Xxx) or as agreed to by the Adviser and Sub-Adviser, the Adviser and Trust will not disclose any list of securities held by the Fund until it is either filed with the Securities & Exchange Commission or mailed out to shareholders, which filing or mailing shall not be made sooner than 30 days after quarter end in any manner whatsoever except as expressly authorized in this Agreement, except that the top 10 holdings may be disclosed 15 days after month end. In addition, at the end of each quarter, the Adviser may disclose to certain third party data or service providers to the Fund, who have entered into a confidentiality agreement with the Adviser, a list of securities purchased or sold by the Fund during the quarter.
